Catalyst Wire Dossier Catalyst Wire Dossier

Tasermity

sevelamer hydrochloride · Genzyme Europe BV
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tasermity, covering 2018-03-27 to 2018-03-27. Get the full timeline:

Most recent: EMA Lapsed: Tasermity (sevelamer hydrochloride) — Genzyme Europe BV

See pricing